Newsroom

Hallym, Uppsala Experts to Discuss Biomarkers in Sweden

No.2846 Date2011-04-01 Hit 32344

The 4th Hallym-Uppsala International Symposium will be held on Wednesday, May 4, 2011, at Rudbeck Laboratory of Uppsala University, Sweden. The theme of this year’s meeting is “Biomarkers: From Bench to Clinic.”

A seven-member Hallym medical delegation headed by Dr. Dai-Won Yoon, Chairman of the Board of Trustees of Ilsong Educational Foundation will visit Sweden for the symposium. Among the delegates include Dr. Hae-Ran Lee, President of Hallym University Medical Center, and Dr. Yong-Sun Kim, Executive Vice President of Health and Biomedical Sciences of Hallym University.

Since 2008, the two institutions have collaborated on a series of annual symposiums to address the latest issues in medicine and surgery. In addition to this, Dr. Anders Hallberg, President of Uppsala University and Dr. Kjell Oberg, Honorary Dean of the Faculty of Medicine visited Hallym in 2008 and 2010. Meeting Hallym members, they agreed to further solidify the bilateral cooperation on basic and clinical medicine by sharing extensive knowledge and expertise.

The specific programs of the symposium including speakers and topics are as follows:

[Hallym Speakers]

■ Biomarkers in cervical incompetence
Professor Keun-Young Lee, Hallym University
■ New approach to biomarker discovery in prion disease
Professor Eun-Kyoung Choi, Hallym University
■ Cardiac biomarkers in acute coronary syndrome
Assistant Professor Seonghoon Choi, Hallym University
■ Biomarkers of liver fibrosis
Professor Dong Joon Kim, Hallym University

[Uppsala Speakers]

■ New techniques in development of biomarkers
Professor Ulf Landegren, Uppsala University
■ The human protein atlas
Core Manager at Human Protein Atlas Project Per-Henrik Edqvist, Uppsala University
■ New biomarkers in Alzheimer disease
Professor Lars Lannfelt, Uppsala University
■ Biomarkers in cardiology and Uppsala Clinical Research Centre (UCR)
Assoc.Professor Bertil Lindahl, Uppsala University
■ Biomarkers in neuroendocrine tumors
Professor Kjell Oberg, Uppsala University

By Younghee Han, Int’l Operations Team, HUMC (symposium@hallym.or.kr)